In this study, we determined the amount of GLUN2B and GLUN2A, and assessed the activitity of CREB and Rac1 (downstream effectors of NMDARs) in healthy and epilepsy-prone rats following p-cresol treatment. The gene discussed is RAC1; the disease is epilepsy.